Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fulgent Genetics, Inc. - Common Stock (NQ:FLGT)

21.78 -0.54 (-2.42%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 182,469
Open 22.35
Bid (Size) 21.00 (20)
Ask (Size) 21.82 (9)
Prev. Close 22.32
Today's Range 21.50 - 22.37
52wk Range 14.57 - 23.56
Shares Outstanding 29,926,846
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Fulgent (FLGT) Q2 Revenue Jumps 16%
Via The Motley Fool
Why Fulgent Genetics Stock Was Crushing It on Friday
The next-generation diagnostics specialist had a beat-and-raise second quarter. 
Via The Motley Fool

Performance

YTD
+18.2%
+18.2%
1 Month
+5.7%
+5.7%
3 Month
-0.0%
-0.0%
6 Month
+24.8%
+24.8%
1 Year
+2.8%
+2.8%

More News

Read More
Monolithic Power Systems, Workiva, Interface, AppFolio And Other Big Stocks Moving Higher On Friday
Via Benzinga
These stocks that are showing activity before the opening bell on Friday.
Via Chartmill
Fulgent Genetics Earnings Preview
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Fulgent Reports Second Quarter 2025 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
Fulgent Genetics Receives EU CE Mark for FulgentExome & FulgentPLM
From Fulgent Genetics, Inc.
Via Business Wire
Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Semler, Adtran, and Fulgent and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Earnings Scheduled For August 1, 2025
Via Benzinga
Fulgent to Announce Second Quarter 2025 Financial Results on Friday, August 1, 2025
From Fulgent Genetics, Inc.
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
From Pomerantz LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Abacus, GoHealth, and Fulgent and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
Via ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
Via ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
Via ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
Via ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
Via ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
From Pomerantz LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Semler, ADTRAN, and Fulgent and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire

Frequently Asked Questions

Is Fulgent Genetics, Inc. - Common Stock publicly traded?
Yes, Fulgent Genetics, Inc. - Common Stock is publicly traded.
What exchange does Fulgent Genetics, Inc. - Common Stock trade on?
Fulgent Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Fulgent Genetics, Inc. - Common Stock?
The ticker symbol for Fulgent Genetics, Inc. - Common Stock is FLGT on the Nasdaq Stock Market
What is the current price of Fulgent Genetics, Inc. - Common Stock?
The current price of Fulgent Genetics, Inc. - Common Stock is 21.78
When was Fulgent Genetics, Inc. - Common Stock last traded?
The last trade of Fulgent Genetics, Inc. - Common Stock was at 09/10/25 04:00 PM ET
What is the market capitalization of Fulgent Genetics, Inc. - Common Stock?
The market capitalization of Fulgent Genetics, Inc. - Common Stock is 651.81M
How many shares of Fulgent Genetics, Inc. - Common Stock are outstanding?
Fulgent Genetics, Inc. - Common Stock has 652M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.